alcohol glp 1 GLP-1 Anti-Obesity Rx and and Substance Use Disorders GLP-1 drugs linked to lower
Description
If this sounds familiar, you are not imagining it
In major clinical trials, such as the landmark STEP 1 trial published in the New England Journal of Medicine , a once-weekly injection of semaglutide 2.4 mg resulted in an average body weight reduction of roughly 14.9% over 68 weeks
This hormone plays a role in regulating appetite, digestion, and blood sugar levels
The FDA decision is expected in mid-2026
